Peptide News Digest

#Ro

1 story

Industry · View digest

Hims & Hers Drops 6% as Amazon One Medical GLP-1 Program Competitive Pressure Intensifies

Telehealth rival Hims & Hers Health shares slid 6% April 21-22 after Amazon's One Medical launched a comprehensive GLP-1 weight management program offering Wegovy and Foundayo starting at $25/month with insurance or $149/month cash-pay for oral options. The move positions Amazon against established telehealth obesity care providers (Hims, Ro, LifeMD, Noom) as the compounded-GLP-1 era winds down.